pillbase.ru

Evenity

Active substance: Romosozumab

INJECTION, SOLUTION · ROMOSOZUMAB 105 mg/1.17mL

United StatesActive

Marketing holder: Amgen, Inc

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • ИВЕНИТИ®
    раствор для подкожного введения, 90 мг/мл, 1.17 мл (original in Russian, GRLS)
    ЛП-№(009365)-(РГ-RU)
    Амджен Европа Б.В.
  • Ивенити®
    раствор для подкожного введения, 90 мг/мл, 1.17 мл (original in Russian, GRLS)
    ЛП-008616
    Амджен Европа Б.В.
EU 1
  • Evenity
    romosozumab
    EMEA/H/C/004465
    UCB Pharma S.A.
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-a4a2-7d7c-ad73-9bb3f6fc3ce3,01a120c6-19ea-72db-829d-be33280daec7;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a12091-e0b5-751a-ab0a-5e49e6ec2030,01a12093-c4f8-7f7e-9b1c-92226bd34f40,01a1209b-3cb2-7121-8efb-9d7b151beaca;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
55513-998
Registration status
Active
Dispensing
Prescription only
Route
SUBCUTANEOUS
Sources
  • product · openFDA NDC · 55513-998 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 55513-998 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 55513-998 · Verified 2026-10-09 · open in source